Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Mabs|May 2, 2015
An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functionsMichelle Kinder, Allison R Greenplate, William R Strohl, et al.
Trends in Pharmacological Sciences|January 1, 2016
Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus InfectionsWilliam E Sause, Peter T Buckley, William R Strohl, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 27, 2022
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the VariantsWilliam R Strohl, Zhiqiang Ku, Zhiqiang An, et al.
Antibody Therapeutics|November 9, 2018
Frontiers and Opportunities: Highlights of the 2<sup>nd</sup> Annual Conference of the Chinese Antibody SocietyHongyu Zhang, Mi Deng, Peng Lin, et al.
Viruses|May 25, 2024
SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic StrategiesHailong Guo, Sha Ha, Jason W Botten, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2015
Trastuzumab triggers phagocytic killing of high HER2 cancer cells in vitro and in vivo by interaction with Fcγ receptors on macrophagesYun Shi, Xuejun Fan, Hui Deng, et al.
AIDS Research and Human Retroviruses|December 24, 2008
Short communication: In vitro synergy between peptides or neutralizing antibodies targeting the N- and C-terminal heptad repeats of HIV Type 1 gp41Renee Hrin, Donna L Montgomery, Fubao Wang, et al.
Methods (San Diego, Calif.)|July 23, 2013
An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbationsOmid Vafa, Gary L Gilliland, Randall J Brezski, et al.
Breast Cancer Research : BCR|August 10, 2012
A single proteolytic cleavage within the lower hinge of trastuzumab reduces immune effector function and in vivo efficacyXuejun Fan, Randall J Brezski, Ming Fa, et al.
Journal of Immunological Methods|March 17, 2007
Automated high-throughput purification of antibody fragments to facilitate evaluation in functional and kinetic based assaysBin Su, Renee Hrin, Barrett R Harvey, et al.
Pageof 3